|
|
||||||||
Creighton University, Osteoporosis Research Center, Omaha, Nebraska
Address reprint requests to: Joan M. Lappe, Ph.D., Creighton University Medical Center, Osteoporosis Research Center, 601 North 30th StreetSuite 4820, Omaha, NE 68131. E-mail: jmlappe{at}creighton.edu
Background: Inadequate vitamin D nutritional status is increasingly recognized as common in North American and European populations, but the extent of the shortfall and the parameters of the distribution for populations of interest remain uncertain.
Purpose: To report the distribution of values for serum 25-hydroxyvitamin D [25(OH)D] in a population of rural postmenopausal women, together with quantification of factors related to vitamin D status.
Setting: Nine largely agrarian counties in eastern Nebraska (
41° N).
Participants: A population-based sample of 1,179 women 55 years of age and older recruited into a four-year trial of calcium and vitamin D supplementation.
Methods: Baseline biochemical, dietary, and anthropometric measurements obtained on entry into trial.
Results: Serum 25(OH)D concentration at baseline varied cyclically with season, with the solar cycle explaining 2.9% of the total variance (P < 0.001). Mean seasonally adjusted 25(OH)D concentration was 71.1 nmol/L. Serum 25(OH)D also exhibited the expected inverse curvilinear relationship with serum parathyroid hormone (PTH), with the inflection point of the curve located at approximately 80 nmol/L. Supplements containing vitamin D were regularly taken by 59% of the cohort (median dose: 200 IU/d). Nevertheless, approximately 4% of all women had values below the laboratory reference range and more than two-thirds fell below 80 nmol/L. Seasonally adjusted serum 25(OH)D concentration was positively correlated with the size of daily vitamin D supplement dose, and negatively with age, weight, and body mass index (P < 0.01 for all). In stepwise multiple linear regression models, weight, age, and supplement dose were independently correlated with seasonally adjusted serum 25(OH)D, and together explained 19% of the total variance of adjusted 25(OH)D concentration. Women taking supplements had only one-sixth the chance of having a 25(OH)D value below the reference limit of the assay, compared to women who did not use supplements.
Conclusions: Approximately two-thirds of this rural population fell below 80 nmol/L, a value considered to be the lower end of the optimal range. Based on the slope of 25(OH)D on supplement dose observed in these women, it would require an additional vitamin D input of nearly 2000 IU/d to reach the goal of an RDA for vitamin D, i.e., to bring 97.5% of the cohort to levels of 80 nmol/L or higher.
Key words: vitamin D, 25-hydroxyvitamin D, parathyroid hormone, calcium intake, supplements, post-menopause
This article has been cited by other articles:
![]() |
R. P. Heaney Vitamin D in Health and Disease Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1535 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prentice, G. R Goldberg, and I. Schoenmakers Vitamin D across the lifecycle: physiology and biomarkers Am. J. Clinical Nutrition, August 1, 2008; 88(2): 500S - 506S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Lappe and R. P Heaney Results may not be generalisable BMJ, February 23, 2008; 336(7641): 403 - 403. [Full Text] [PDF] |
||||
![]() |
M. J Bolland, A. B Grey, R. W Ames, B. H Mason, A. M Horne, G. D Gamble, and I. R Reid The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency Am. J. Clinical Nutrition, October 1, 2007; 86(4): 959 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Lappe, D. Travers-Gustafson, K M. Davies, R. R Recker, and R. P Heaney Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1586 - 1591. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |